Overture Tx
1 known investors
Overture develops precision antibody therapeutics for obesity treatment, targeting metabolic dysfunction pathways to reduce fat mass while preserving lean muscle through monthly-dosed therapeutic approaches.
BiotechHealthtechMedical Devices